Lemaitre Vascular IncLMAT
Price$80.19Intrinsic value$107.5034% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $107.50median of 6 methods · middle span $61-$125based on filings through 30 Jun 2026
Market Price $80.19Price as of 1 Oct 2026
Margin of Safety +34.1%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 8.5% (near-term consensus, capped) · years 2–5: 11.2%/yr (balance of the path).10.6% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 611.1%Yr 711.0%Yr 810.8%Yr 910.7%Yr 1010.6%
11.2% → 10.6%
Years 11–20: glide to long-run rate
Per-year rates
Yr 119.9%Yr 129.1%Yr 138.3%Yr 147.6%Yr 156.8%Yr 166.1%Yr 175.3%Yr 184.5%Yr 193.8%Yr 203.0%
10.6% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)19.2%
Discount rate (cost of equity) 8.0%
Volatility vs market (adjusted beta)0.69

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetLemaitre Vascular IncLMATHealth Care
Valuation
P/E28.0×
P/S6.9×
P/B4.6×
EV / Revenue7.5×
EV / EBITDA—
Profitability
Gross margin72.7%
Operating margin26.7%
Net margin25.0%
FCF margin28.1%
Returns
ROE15.6%
ROA10.3%
ROIC11.7%
Growth
Revenue growth (YoY)19.4%
5-yr fwd EPS growth10.6%
Financial strength
Debt / Equity0.40×
Current ratio16.31×
Altman Z-Score7.2
Interest coverage—
Dividend yield0.6%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.